UBS Group’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,124
Closed -$2.04K 9037
2023
Q1
$2.04K Sell
2,124
-3,663
-63% -$3.51K ﹤0.01% 7501
2022
Q4
$2.84K Sell
5,787
-2,919
-34% -$1.43K ﹤0.01% 8416
2022
Q3
$12K Buy
8,706
+4,658
+115% +$6.42K ﹤0.01% 7133
2022
Q2
$7K Sell
4,048
-6
-0.1% -$10 ﹤0.01% 7546
2022
Q1
$10K Buy
4,054
+474
+13% +$1.17K ﹤0.01% 7425
2021
Q4
$13K Sell
3,580
-812
-18% -$2.95K ﹤0.01% 7382
2021
Q3
$18K Buy
4,392
+3,335
+316% +$13.7K ﹤0.01% 6168
2021
Q2
$6K Sell
1,057
-835
-44% -$4.74K ﹤0.01% 7377
2021
Q1
$14K Buy
1,892
+1,392
+278% +$10.3K ﹤0.01% 6671
2020
Q4
$4K Sell
500
-209
-29% -$1.67K ﹤0.01% 6915
2020
Q3
$7K Sell
709
-918
-56% -$9.06K ﹤0.01% 6277
2020
Q2
$17K Buy
1,627
+527
+48% +$5.51K ﹤0.01% 5821
2020
Q1
$8K Sell
1,100
-1,964
-64% -$14.3K ﹤0.01% 6184
2019
Q4
$32K Buy
3,064
+2,166
+241% +$22.6K ﹤0.01% 5548
2019
Q3
$9K Buy
898
+398
+80% +$3.99K ﹤0.01% 6269
2019
Q2
$6K Sell
500
-362
-42% -$4.34K ﹤0.01% 6463
2019
Q1
$17K Sell
862
-453
-34% -$8.93K ﹤0.01% 5614
2018
Q4
$24K Sell
1,315
-503
-28% -$9.18K ﹤0.01% 5731
2018
Q3
$48K Sell
1,818
-6
-0.3% -$158 ﹤0.01% 5302
2018
Q2
$54K Buy
1,824
+351
+24% +$10.4K ﹤0.01% 5019
2018
Q1
$50K Buy
1,473
+427
+41% +$14.5K ﹤0.01% 4868
2017
Q4
$46K Buy
1,046
+173
+20% +$7.61K ﹤0.01% 4955
2017
Q3
$49K Sell
873
-384
-31% -$21.6K ﹤0.01% 4928
2017
Q2
$53K Buy
1,257
+846
+206% +$35.7K ﹤0.01% 4695
2017
Q1
$11K Buy
411
+347
+542% +$9.29K ﹤0.01% 5644
2016
Q4
$1K Buy
+64
New +$1K ﹤0.01% 6660
2016
Q3
Sell
-522
Closed -$13K 6908
2016
Q2
$13K Sell
522
-754
-59% -$18.8K ﹤0.01% 5749
2016
Q1
$56K Sell
1,276
-1,744
-58% -$76.5K ﹤0.01% 4633
2015
Q4
$165K Buy
3,020
+331
+12% +$18.1K ﹤0.01% 3895
2015
Q3
$112K Sell
2,689
-102,409
-97% -$4.27M ﹤0.01% 4130
2015
Q2
$5.47M Buy
+105,098
New +$5.47M ﹤0.01% 1546